DNA blood test improves patient selection for radiopharmaceutical therapy in prostate cancer
A noninvasive DNA blood test can identify metastatic castration-resistant prostate cancer (mCRPC) patients who are most likely to benefit from 223Ra radiopharmaceutical therapy and monitor their progress throughout treatment, according…
High resolution ultrasound could enable faster prostate cancer diagnosis
Biopsies guided by high resolution ultrasound are as effective as those using MRI in diagnosing prostate cancer, an international clinical trial has shown. The technology, called micro-ultrasound, is cheaper and…